partnership series seminar 2: Translating from target to clinical trial: What you need to know about preclinical studies
Date: Tuesday 26 July 2022
Time: 1:00pm - 2:00pm
Recording: TRANSLATING FROM TARGET TO CLINICAL TRIAL: WHAT YOU NEED TO KNOW ABOUT PRECLINICAL STUDIES - YouTube
So you are looking for or have identified a potential target for a therapeutic? What studies will you need to do to progress your research through preclinical studies, hopefully to a clinical trial? In this seminar, you'll hear from a range of leading experts on the drug development stages, the type of support that is available for drug development and formulation, scale-up production and importantly, the regulatory requirements you'll need to meet. This seminar is a must if you are looking at therapeutic targets in your research, even if you're not up to preclincial studies.
Speakers
- Dr Vanessa Zann, Senior Drug Development Consultant, Quotient Sciences
- Dr Andrew Harvey, Director QEDDI, UniQuest
- Dr Trent Munroe, Senior Vice President of Therapeutics, Microba
- Dr Mark Reid, Founder and Managing Director, Graythan Regulatory Services
Panel
- Prof Josephine Forbes, Group Leader, Mater Research - NHMRC Senior Research Fellow
- Prof Ranjeny Thomas, Group Leader, Arthritis Qld Chair of Rheumatology, UQDI
- Dr Simon Cashion, Research Partnerships Manager, Faculty of Medicine, UQ
